Indapamide SR 1.5mg in the treatment of hypertension: optimising patient outcomes ; a seminar-in-print
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Auckland [u.a.]
Adis Internat.
2000
|
| Series: | Drugs / Supplement
59,2 |
| Subjects: | |
| Physical Description: | 40 S. graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012977256 | ||
| 003 | DE-604 | ||
| 005 | 20050726 | ||
| 007 | t | ||
| 008 | 000208s2000 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)45703196 | ||
| 035 | |a (DE-599)BVBBV012977256 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 | ||
| 245 | 1 | 0 | |a Indapamide SR 1.5mg in the treatment of hypertension |b optimising patient outcomes ; a seminar-in-print |c guest ed. Jean-Michel Mallion |
| 264 | 1 | |a Auckland [u.a.] |b Adis Internat. |c 2000 | |
| 300 | |a 40 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs / Supplement |v 59,2 | |
| 650 | 4 | |a Hypertension |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Hypertension |x drug therapy |v Congresses | |
| 650 | 4 | |a Sulfonamides |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Mallion, Jean-Michel |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement |t Drugs |v 59,2 |w (DE-604)BV000904909 |9 59,2 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008841434 | ||
Record in the Search Index
| _version_ | 1804127674268909568 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV012977256 |
| ctrlnum | (OCoLC)45703196 (DE-599)BVBBV012977256 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01083nam a2200313 cb4500</leader><controlfield tag="001">BV012977256</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050726 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000208s2000 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)45703196</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012977256</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Indapamide SR 1.5mg in the treatment of hypertension</subfield><subfield code="b">optimising patient outcomes ; a seminar-in-print</subfield><subfield code="c">guest ed. Jean-Michel Mallion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland [u.a.]</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">40 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs / Supplement</subfield><subfield code="v">59,2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sulfonamides</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mallion, Jean-Michel</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Drugs</subfield><subfield code="v">59,2</subfield><subfield code="w">(DE-604)BV000904909</subfield><subfield code="9">59,2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008841434</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV012977256 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:37:06Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008841434 |
| oclc_num | 45703196 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| physical | 40 S. graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Adis Internat. |
| record_format | marc |
| series2 | Drugs / Supplement |
| spelling | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print guest ed. Jean-Michel Mallion Auckland [u.a.] Adis Internat. 2000 40 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs / Supplement 59,2 Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Sulfonamides Congresses (DE-588)1071861417 Konferenzschrift gnd-content Mallion, Jean-Michel Sonstige oth Supplement Drugs 59,2 (DE-604)BV000904909 59,2 |
| spellingShingle | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Sulfonamides Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print |
| title_auth | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print |
| title_exact_search | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print |
| title_full | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print guest ed. Jean-Michel Mallion |
| title_fullStr | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print guest ed. Jean-Michel Mallion |
| title_full_unstemmed | Indapamide SR 1.5mg in the treatment of hypertension optimising patient outcomes ; a seminar-in-print guest ed. Jean-Michel Mallion |
| title_short | Indapamide SR 1.5mg in the treatment of hypertension |
| title_sort | indapamide sr 1 5mg in the treatment of hypertension optimising patient outcomes a seminar in print |
| title_sub | optimising patient outcomes ; a seminar-in-print |
| topic | Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Sulfonamides Congresses |
| topic_facet | Hypertension Chemotherapy Congresses Hypertension drug therapy Congresses Sulfonamides Congresses Konferenzschrift |
| volume_link | (DE-604)BV000904909 |
| work_keys_str_mv | AT mallionjeanmichel indapamidesr15mginthetreatmentofhypertensionoptimisingpatientoutcomesaseminarinprint |